424 related articles for article (PubMed ID: 10827385)
1. Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trial.
Heidland UE; Heintzen MP; Michel CJ; Strauer BE
Am Heart J; 2000 Jun; 139(6):1039-45. PubMed ID: 10827385
[TBL] [Abstract][Full Text] [Related]
2. [Intracoronary dipyridamole reduces the incidence of acute coronary vessel occlusion in percutaneous transluminal coronary angioplasty--a prospective randomized study].
Heintzen MP; Heidland UE; Klimek WJ; Michel CJ; Kelm M; Leschke M; Schwartzkopff B; Vester EG; Strauer BE
Z Kardiol; 1997 Dec; 86(12):961-7. PubMed ID: 9499493
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial.
Heintzen MP; Heidland UE; Klimek WJ; Leschke M; Kelm M; Schwartzkopff B; Vester EG; Michel CJ; Strauer BE
Heart; 2000 May; 83(5):551-6. PubMed ID: 10768906
[TBL] [Abstract][Full Text] [Related]
4. [Effect of intracoronary dipyridamole administration on the incidence of restenosis after PTCA. A prospective randomized study].
Heidland UE; Klimek WJ; Michel CJ; Heintzen MP; Strauer BE
Med Klin (Munich); 1998 Oct; 93(10):579-84. PubMed ID: 9849048
[TBL] [Abstract][Full Text] [Related]
5. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
[TBL] [Abstract][Full Text] [Related]
6. Restenosis following placement of an intracoronary heparin treated tantulum stent in the hyperlipidemic miniature swine model.
Jenkins JS; Webel R; Laughlin MH; Rowland SM; Yoklavich MF; Amann JF; Branson K; Myers PR
J Invasive Cardiol; 1995; 7(6):173-82. PubMed ID: 10155102
[TBL] [Abstract][Full Text] [Related]
7. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.
Erbel R; Haude M; Höpp HW; Franzen D; Rupprecht HJ; Heublein B; Fischer K; de Jaegere P; Serruys P; Rutsch W; Probst P
N Engl J Med; 1998 Dec; 339(23):1672-8. PubMed ID: 9834304
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.
Hausleiter J; Kastrati A; Mehilli J; Schühlen H; Pache J; Dotzer F; Glatthor C; Siebert S; Dirschinger J; Schömig A;
J Intern Med; 2004 Nov; 256(5):388-97. PubMed ID: 15485474
[TBL] [Abstract][Full Text] [Related]
9. Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.
Gibson CM; Goel M; Cohen DJ; Piana RN; Deckelbaum LI; Harris KE; King SB
J Am Coll Cardiol; 1998 Jul; 32(1):28-34. PubMed ID: 9669245
[TBL] [Abstract][Full Text] [Related]
10. Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty.
Gurbel PA; Navetta FI; Bates ER; Muller DW; Tenaglia AN; Miller MJ; Muhlstein B; Hermiller JB; Davidson CJ; Aguirre FV; Beauman GJ; Berdan LG; Leimberger JD; Bovill EG; Christenson RH; Ohman EM
Cathet Cardiovasc Diagn; 1996 Apr; 37(4):382-91. PubMed ID: 8721695
[TBL] [Abstract][Full Text] [Related]
11. Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty: a matched case-control study.
Lincoff AM; Topol EJ; Chapekis AT; George BS; Candela RJ; Muller DW; Zimmerman CA; Ellis SG
J Am Coll Cardiol; 1993 Mar; 21(4):866-75. PubMed ID: 8450155
[TBL] [Abstract][Full Text] [Related]
12. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
[TBL] [Abstract][Full Text] [Related]
13. Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase.
Kelly RV; Crouch E; Krumnacher H; Cohen MG; Stouffer GA
Catheter Cardiovasc Interv; 2005 Nov; 66(3):327-32. PubMed ID: 16208711
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
[TBL] [Abstract][Full Text] [Related]
15. [Acute coronary vessel occlusion after PTCA--possibility of risk stratification using quantitative coronary angiography, clinical determinants and laboratory chemistry parameters].
Heidland UE; Klimek WJ; Michel CJ; Willers R; Heintzen MP; Strauer BE
Z Kardiol; 1997 Dec; 86(12):982-9. PubMed ID: 9499496
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.
Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
J Am Coll Cardiol; 1996 Nov; 28(5):1119-26. PubMed ID: 8890804
[TBL] [Abstract][Full Text] [Related]
17. Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial.
van den Brand M; Laarman GJ; Steg PG; De Scheerder I; Heyndrickx G; Beatt K; Kootstra J; Simoons ML
Eur Heart J; 1999 Nov; 20(21):1572-8. PubMed ID: 10529325
[TBL] [Abstract][Full Text] [Related]
18. Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty.
Wöhrle J; Grebe OC; Nusser T; Al-Khayer E; Schaible S; Kochs M; Hombach V; Höher M
Circulation; 2003 Apr; 107(14):1840-3. PubMed ID: 12682003
[TBL] [Abstract][Full Text] [Related]
19. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting.
Leon MB; Teirstein PS; Moses JW; Tripuraneni P; Lansky AJ; Jani S; Wong SC; Fish D; Ellis S; Holmes DR; Kerieakes D; Kuntz RE
N Engl J Med; 2001 Jan; 344(4):250-6. PubMed ID: 11172151
[TBL] [Abstract][Full Text] [Related]
20. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group.
Grines CL; Cox DA; Stone GW; Garcia E; Mattos LA; Giambartolomei A; Brodie BR; Madonna O; Eijgelshoven M; Lansky AJ; O'Neill WW; Morice MC
N Engl J Med; 1999 Dec; 341(26):1949-56. PubMed ID: 10607811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
